For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter, Facebook and LinkedIn.
Radiology DU Ltd: Est 2011
The Transflux multiuse contrast delivery system is leading the paradigm shift away from the environmentally unsustainable and uneconomical single use method of contrast delivery. The designers of Transflux, P&R Medical, have worked with Europe’s leading University Hospital (Leuven, Belgium) to develop the scientifically proven 100% safe multiuse contrast system. Transflux enables the end user to unlock the full potential of their existing dual head injector without the hassle and wastage normally associated with personalized injections or techniques requiring a saline bolus. …. enabling you to do contrast media injections a better way - saving time, waste and money.